The research and development of new drugs for these two important bile acids receptors is expected to become a new choice to improve glucose homeostasis regulate lipid metabolism and treat NAFLD‐associated liver injury.43 This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.